...
首页> 外文期刊>Journal of Clinical Neurophysiology >Visual-evoked potentials to onset of chromatic red-green and blue-yellow gratings in Parkinson's disease never treated with L-dopa.
【24h】

Visual-evoked potentials to onset of chromatic red-green and blue-yellow gratings in Parkinson's disease never treated with L-dopa.

机译:视觉诱发的彩色帕金森氏病红绿色和蓝黄色光栅发作的可能性从未用左旋多巴治疗。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The differential dysfunction of chromatic and achromatic visual pathways in early Parkinson's disease (PD) was evaluated by means of visual-evoked potentials (VEPs) recorded in 12 patients (mean age 60.1 +/- 8.3 years; range 46 to 74 years) in the early stages of PD and not yet undergoing treatment with L-dopa, and in 12 age-matched controls. Visual stimuli were full-field (14 deg) equiluminant red-green (R-G), blue-yellow (B-Y), and black-white (B-W) sinusoidal gratings of two cycles per degree, presented in onset (300 milliseconds)--offset (700 milliseconds) mode, at two contrast (K) levels (90% and 25%). The VEP mean latencies were significantly more delayed in PD patients than in controls for chromatic than for luminance stimuli, in particular for B-Y stimuli of low contrast (K90%: B-W = 6.6 milliseconds, R-G = 3.34 milliseconds, B-Y = 15.48 milliseconds; K25%: B-W = 7.8 milliseconds, R-G = 14.8 milliseconds, B-Y = 28.9). Latencies of chromatic VEPs were more variable that achromatic VEP latencies in both normal subjects and PD patients. Therefore, the frequency of latency abnormalities (within 30%) was not significantly different for the three visual stimuli. Our results show that, in addition to achromatic VEPs, chromatic VEPs are impaired in early PD patients not yet undergoing L-dopa therapy, indicating an acquired color deficiency in these patients. The greater delay for the B-Y VEPs suggests a higher vulnerability of visual blue-cone pathway in the early stages of the disease. However, the overall sensitivity of chromatic VEPs in detecting early visual impairment in PD is comparable with that of achromatic VEPs.
机译:在帕金森氏病(PD)中,通过视觉诱发电位(VEP)记录了12例患者(平均年龄60.1 +/- 8.3岁;范围46到74岁)中彩色和无彩色视觉通路的功能障碍。 PD的早期阶段,尚未接受L-多巴的治疗,并在12个年龄匹配的对照组中进行。视觉刺激是每度两个周期的全场(14度)等亮度红绿色(RG),蓝黄色(BY)和黑白(BW)正弦光栅,以开始(300毫秒)-偏移表示(700毫秒)模式,两个对比度(K)级别(90%和25%)。 PD患者的VEP平均潜伏期比对照组的延迟要明显长于彩色刺激,而不是亮度刺激,尤其是低对比度的BY刺激(K90%:BW = 6.6毫秒,RG = 3.34毫秒,BY = 15.48毫秒; K25% :BW = 7.8毫秒,RG = 14.8毫秒,BY = 28.9)。在正常人和PD患者中,有色VEP的潜伏期比无色VEP潜伏期更大。因此,三种视觉刺激的潜伏期异常频率(30%以内)没有显着差异。我们的结果表明,除了消色差的VEP之外,尚未接受L-多巴治疗的早期PD患者中的彩色VEP也会受损,表明这些患者获得了后天的颜色不足。 B-Y VEP的更大延迟表明在疾病的早期阶段,视觉蓝锥途径的脆弱性更高。但是,彩色VEP在检测PD早期视觉损伤方面的总体敏感性与非彩色VEP相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号